Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Dysplasia, Cervix
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Assessments of pain through pain score parameter
- Last Updated
- 3 years ago
Overview
Brief Summary
To evaluate the effectiveness of virtual reality glasses as a distraction technique in the management of acute pain and anxiety during conization of cervix uterus under local anesthesia
Detailed Description
A prospective, open-label, randomized control trial in a tertiary university affiliated medical center between March 2021 to March 2023. Overall, 100 women referred for conization of cervix due to cervical dysplasia will be randomly allocated to undergo conization either with the use of virtual reality glasses (study group) or with standard treatment (control group). The primary outcome measures will include self-reported pain, anxiety scores, and vital signs as an indirect measurement of pain and anxiety, including pulse rate (PR) and respiratory rate (RR). Pain and anxiety outcomes will be measured as numeric rating scores.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients over 18 years referred for conization of cervix due to cervical dysplasia
Exclusion Criteria
- •patients under 18 years
- •pregnant women
Outcomes
Primary Outcomes
Assessments of pain through pain score parameter
Time Frame: 20 minutes
Assessments of pain through pain score parameter of the NRS questionnaire. Pain will be measured using the Numeric Rating Scale (NRS) which is a 11 point scale from 0 to 10 which is a validated score of measuring pain in which 0 is no pain and 10 is the worst imaginable pain
Assessments of pain through physiological parameters
Time Frame: 20 minutes
Assessments of pain through physiological parameters of pulse rate. Heart Rate will be measured using heart rate beats per minute